VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s share price traded down 14.7% on Wednesday . The company traded as low as C$0.15 and last traded at C$0.15. 266,015 shares traded hands during mid-day trading, a decline of 10% from the average session volume of 294,436 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Performance
The business’s 50-day simple moving average is C$0.10 and its two-hundred day simple moving average is C$0.13. The firm has a market cap of C$23.52 million, a price-to-earnings ratio of -4.48 and a beta of 0.39. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- What is a support level?
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Canadian Penny Stocks: Can They Make You Rich?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
